Biotech

All Articles

Lilly, Haya ink $1B biobuck being overweight treaty to browse black genome

.Eli Lilly's look for being overweight intendeds has led it to the darker genome. The Big Pharma has...

ArsenalBio raises $325M, rotates out of previous lead resource

.Arsenal Biosciences is going on up. The cell treatment provider has added on $325 thousand in ammo ...

Lilly- backed fat burning biotech data IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...

Aelis' cannabis use medication fails stage 2b, steering Indivior to rethink $100M option

.Aelis Farma's hopes of securing an easy, beneficial choice on a $100 thousand option payment have f...

ProKidney halts period 3 test certainly not required for cell treatment approval

.ProKidney has ceased some of a set of stage 3 tests for its own tissue treatment for kidney ailment...

Vaxcyte climbs on 'magnificent' 31-valent PCV win against Pfizer

.Vaxcyte introduced what analysts referred to as "stunning" period 1/2 information for its own 31-va...

Recursion's brain health condition test presents scant documentation of effectiveness

.Recursion has actually discovered by means of a very early examination of its tech-enabled strategy...

Acepodia, Pfizer click on with each other for chemistry-based cell therapy

.Call it a scenario of great chemical make up: Acepodia, a biotech based upon Nobel Champion scienti...

Praxis epilepsy drug decreases seizures in stage 2 hearing

.Praxis Preciseness Medicines has actually racked up an additional midphase win in epilepsy this yea...

Three directors surrender as Dyne posts mixed information for DMD prospect

.After running away a medical grip many years back, Dyne Therapy has actually shown new period 1/2 r...